CROS NT - Contract Research Organization

26.04.12 CROS NT Appoints Business Development Manager to Further Expansion in Germany

mary.wieder — Thu, 26 Apr 2012 15:29:10 +0000

Verona, Italy (26 April 2012) – This month, CROS NT has appointed Eva Hurst as Business Development Manager with a focus on furthering the expansion of its Augsburg office which opened in 2010.

Eva joins CROS NT from a Spanish full-service CRO, where she was involved in international business development and project management for the past three years. She was responsible for establishing a network of regional service providers. Having hands-on experience as a Project Manager and knowing the full project life cycle will allow her to work in a consultative manner with customers.

CROS NT is experiencing steady growth as more and more Sponsors of clinical trials decide to place their data with CROS NT so that all study data for a single product can be handled in a consistent traceable manner by one provider (services include data management, statistics, pharmacovigilance and medical writing).

Eva will join CROS NT at the Outsourcing in Clinical Trials Europe event in Zurich on 8-9 May where CROS NT will be an exhibitor.

“We are excited to have Eva join our Business Development team. Her international experience and skill set in the clinical trial environment make her the ideal candidate to grow our business in German-speaking regions. This is an important goal for CROS NT,” says CEO Paolo Morelli.

About CROS NT Group

CROS NT is a global Contract Research Organisation (CRO) specialized in biometrics. Celebrating its 20th anniversary in 2012, CROS NT has created a centre of excellence for clinical trial data, providing services such as Biostatistics (methodology, programming and analysis), Data Management, Medical Writing, Pharmacovigilance and Training.

For more information, please contact Mary Wieder at mary.wieder@crosnt.com

23.04.12 CROS NT to Sponsor German ePharma Day in Frankfurt

mary.wieder — Mon, 23 Apr 2012 08:05:54 +0000

Celebrating its 20th anniversary this year, CROS NT will again sponsor the 3rd Annual German ePharma Day to be held in Frankfurt.

Augsburg, Germany (23 April 2012) – CROS NT, in conjunction with its technology affiliate, is sponsoring the 3rd annual German ePharma Day in Frankfurt on 26 April.

The theme of the ePharma Day series 2012 is “Traceability in Clinical Trials: From Study Design to Submission”. Some topics covered will be eSource documents, EudraCT/OssC, eManagement of Pharmacovigilance, computer systems and advanced technology. The topic of electronic data submissions and technology in clinical trials is very timely.

The ePharma Day series began in 2009 with a one-day conference in Milan, Italy hosted by CROS NT and Easy-b. In 2010, German ePharma Day was added as CROS NT expanded with an office in Augsburg. Last year, the inaugural Spanish ePharma Day was held in Barcelona, Spain. The goal of the ePharma Day series is to promote relevant and timely topics in the pharmaceutical and biotech industry on a national level by inviting local experts to speak. The German ePharma Day series is a dual language event: German and English.

CROS NT and ARITHMOS are also presenting at the conference. Marta Zanus, Senior Statistical Programmer and Senior Project Manager for CROS NT, is presenting on “Traceability in building analysis datasets in clinical studies”. IT Systems Analyst, Gianluigi Albertini, is discussing “Benefits of Centralizing Storage of Clinical Data” for ARITHMOS.

The German ePharma Day conference will be co-chaired by Robert Hermann, Managing Director of cr.appliance and Martin Scott, Director of Numerus Ltd.

There is still time to register for the event. Entrance to the conference includes access to all presentations, a networking lunch and an invitiation to a dinner the night of 25 April at Exenberger Restaurant in Frankfurt.

German ePharma Day is the second event in the ePharma Day series of 2012. The schedule is indicated below. For more information or to register, visit the Easy-b website at http://www.epharmaday.org/.

About CROS NT Group

Click to download the full schedule

For more information please contact Mary Wieder at mary.wieder@crosnt.com

13.04.12 CROS NT to Sponsor Italian ePharma Day in Milan

mary.wieder — Fri, 13 Apr 2012 09:14:17 +0000

Celebrating its 20th anniversary this year, CROS NT will again sponsor the 4th Annual Italian ePharma Day to be held in Milan.

Verona, Italy (13 April 2012) – CROS NT, in conjunction with its technology affiliate, is sponsoring the 4th annual Italian ePharma Day in Milan on 19 April.

The ePharma Day series began in 2009 with a one-day conference in Milan, Italy hosted by CROS NT and Easy-b. In 2010, German ePharma Day was added as CROS NT expanded with an office in Augsburg. Last year, the inaugural Spanish ePharma Day was held in Barcelona, Spain. The goal of the ePharma Day series is to promote relevant and timely topics in the pharmaceutical and biotech industry on a national level by inviting local experts to speak. The Italian ePharma Day series is a dual language event: Italian and English.

CROS NT and ARITHMOS are also presenting at the conference. Marta Zanus, Senior Statistical Programmer and Senior Project Manager for CROS NT, is presenting on “Traceability in building analysis datasets in clinical studies”. Chief Operating Officer of ARITHMOS, Stefano Piccoli, is discussing “Benefits of Centralizing Storage of Clinical Data”.

There is still time to register for the event. Entrance to the conference includes access to all presentations, a networking lunch and an invitiation to a dinner the night of 18 April at Ala Cena Restaurant in Milan.

Italian ePharma Day is the first ePharma Day series of 2012. The schedule is indicated below. For more information or to register, visit the Easy-b website at http://www.epharmaday.org/.

About CROS NT Group

Click to download the full schedule

22.03.12 ARITHMOS Names New Business Development Director and Launches New Software Product for CROs

mary.wieder — Fri, 23 Mar 2012 11:47:24 +0000

Verona, Italy (22 March 2012) – ARITHMOS, an IT partner and solution provider for the clinical trial and pharmaceutical sectors, has recently appointed Chris Hamilton as its Director of Business Development and Marketing. Chris joins ARITHMOS with more than 10 years of experience in the pharmaceutical, CRO and life science technology environment. He has a long history of strategic corporate development and the management of international marketing in the healthcare sector.

Chris will be at the DIA EuroMeeting, 26-28 March in Copenhagen where ARITHMOS is launching its new software, ArithmosCentrum, at Booth #702. This is a unique software platform which manages the information flow between sales, project management, resource management and finance. Specifically designed for CROs, it tracks the status of contracts and proposals, produces project plans and proposals, shows how projects are doing against budget, and tracks the company’s capacity versus its pipeline of work. It also tracks milestone invoicing. All in all, it is a “must see” for CROs.

For any questions or comments, please contact Business Development & Marketing Officer, Mary Wieder, at mary.wieder@crosnt.com

03.2.12 CROS NT Announces ePharma Day Series 2012

mary.wieder — Fri, 27 Jan 2012 11:34:02 +0000

CROS NT and ARITHMOS are sponsoring the ePharma Day series again in 2012. Only this year, the series has grown to include two new countries – Russia and the UK.

Verona, Italy (27 January 2012) – CROS NT and ARITHMOS, in conjunction with Easy-b Marketing and Event Services, has released the schedule and details for the ePharma Day Series 2012. As in past years, the events are to take place in Italy, Germany and Spain. However, two more events have been scheduled for 2012 including one in Russia and one in the United Kindgom.

The theme of the ePharma Day series 2012 is “Traceability in Clinical Trials: from Study Design to Submission” in order to discuss the importance of data traceability in the clinical environemnt since technology has allowed Sponsors to interrogate trial data in more intelligent ways. Some topics covered will be eSource documents, EudraCT/OssC, eManagement of Pharmacovigilance, computer systems and advanced technology. The topic of electronic data submissions and technology in clinical trials is very timely.

The ePharma Day series began in 2009 with a one-day conference in Milan, Italy hosted by CROS NT and Easy-b. In 2010, German ePharma Day was added as CROS NT expanded with an office in Augsburg. Last year, the inaugural Spanish ePharma Day was held in Barcelona, Spain. The goal of the ePharma Day series is to promote relevant and timely topics in the pharmaceutical and biotech industry on a national level by inviting local experts to speak. The ePharma Day series are dual language events: the local language and English.

Due to the growing popularity of the ePharma Day series, two events have been added for 2012. The United Kingdom was a logical choice as CROS NT has expanded operations there this month and has a new Vice President, Andrew MacGarvey. The UK is also a hub for many large pharma companies and CROs.

Russia is an increasingly important market in clinical trials. The Russian market is at the center of the Eastern European growth spurt. Russia is part of the BRICM (Brazil, Russia, India, China, Mexico) emerging markets and the its pharmaceutical market generated $1 billion in 2009 with a growth rate of 14,5 percent.

The schedule for the ePharma Day Series is as follows:

19 APRIL: ITALIAN ePHARMA DAY in Milan, Italy
26 APRIL: GERMAN ePHARMA DAY in Frankfurt, Germany
19 JULY: RUSSIA ePHARMA DAY in Moscow, Russia
(TBD) SEPTEMBRE: UK ePHARMA DAY in London, UK
25 OCTOBER: Spanish ePharma Day in Madrid, Spain

For more information, visit the Easy-b website at http://www.epharmaday.org/. Abstracts for presentations are still being accepted. Please contact Marketing Officer, Mary Wieder, for more information.

13.1.12 ARITHMOS COO to Present on ePRO/EDC Integration for BIAS

mary.wieder — Fri, 13 Jan 2012 12:18:57 +0000

Chief Operating Officer, Stefano Piccoli, will present on the importance of ePRO device integration with EDC systems using ARITHMOS case studies at the BIAS Seminar in Milan.

Verona, Italy (13 January 2011) – ARITHMOS Chief Operating Officer, Stefano Piccoli, is participating in the SSFA and BIAS Seminar on “PRO and ePRO in Clinical Trials” in Milan, Italy on 16 January. The seminar is being hosted by two Italian organizations – Società di Scienze Farmacologiche Applicate and Biometristi dell’Industria Associati – which focus on the pharmaceutical and clinical trial environment in Italy. Stefano is presenting ePRO and eCRF integration using case study examples from ARITHMOS’ extensive work in this area.

Stefano Piccoli, Chief Operating Officer of ARITHMOS

Stefano is presenting on the importance and the benefits of integrating electronic Patient Recorded Outcomes (ePRO) and electronic Case Report Forms (eCRF) with Electronic Data Capture (EDC) systems. The presentation will focus on what is needed to integrate systems and what devices are best for patient compliance and electronic data submission.

The timing of the “PRO and ePRO in Clinical Trials” is relevant due to developments in the ePRO market, especially concerning devices. Stefano is also focusing his presentation on the shift from ePRO to iPRO and how the iPad is an effective device for collecting data due to its intuitive nature and the accessibility of “apps” for health references. The iTunes store has over 7.000 health-related apps.

ARITHMOS is presenting at the seminar because of its expertise in data integration. The second part of Stefano’s presentation will focus on case study examples of ARITHMOS’ work in ePRO device integration with EDC systems. ARITHMOS has worked with its CRO partner, CROS NT, on ePRO integration using a spirometric device in a respiratory phase III study with over 2.000 patients in 175 sites and 14 countries. Additionally, ARITHMOS has experience working with smartphones and tablets including the Blackberry and the iPad and is currently working on a study with ePRO and EDC integration for the iPad.

If you are interested in seeing Stefano’s presentation on ePRO and EDC integration, contact ARITHMOS.

09.1.12 CROS NT Announces Further Expansion into the UK Market, Andrew MacGarvey Joins Team

mary.wieder — Mon, 09 Jan 2012 11:49:23 +0000

CROS NT is pleased to announce the next phase of its European expansion with the hiring of a new VP and the establishment of a UK office.

Verona, Italy (9 January 2012) – CROS NT is starting the new year by announcing its expansion into the United Kingdom. After successfully expanding operations into Germany in 2010 with an office in Augsburg, CROS NT is moving to the UK market with its service offering of superior data management and biostatistics analysis for clinical trials.

Andrew MacGarvey

Andrew MacGarvey, who joined the company on 3 January 2012, will establish UK operations. MacGarvey brings considerable experience to CROS NT having spent over 14 years in the pharmaceutical sector. Andrew has worked for Omnicare, PRA International, Datatrial and Quanticate. During his time at both Datatrial and Quanticate, he helped to grow UK-based operations as well as establishing U.S. offices.

“Andrew is the perfect candidate for this role” says Paolo Morelli, CEO of the CROS NT Group, “he has experience at both establishing new operations and growing them. He will launch CROS in the UK, allowing us to provide closer service for our many customers there. I am delighted to welcome Andrew to our leadership team and to add the UK to our existing hubs in Italy and Germany.”

“I have followed the activities of CROS NT for some time,” says MacGarvey “I am excited by the opportunity to help with the growth of the business. CROS NT are focused on customer care, something that is very important to me. I will be bringing their great service to the UK and ultimately the USA.”

# # #

For more information, please contact Marketing Officer, Mary Wieder, at mary.wieder@crosnt.com or +39 045 820 26 66

20.12.11 ARITHMOS Successfully Integrates Oracle AERS and Oracle Business Intelligence

mary.wieder — Tue, 20 Dec 2011 09:17:41 +0000

Working in conjunction with CROS NT pharmacovigilance services, ARITHMOS invests in technology integration to make pharmacovigilance data more readily available.

Verona, Italy (20 December 2011) – ARITHMOS has been investing in technology developments to meet the needs of the pharmacovigilance market. Led by Head of Health Science Services, Silvia Gabanti, ARITHMOS has successfully integrated Oracle AERS and Oracle Business Intelligence, an investment in outsourced pharmacovigilance work which requires the need to access real-time data and results.

As an Oracle Business Process Outsourcing Partner for the life sciences industry, ARITHMOS can use and understand Oracle applications to offer a premium value package to its clients.

The proposed solution by ARITHMOS is an integration of the Oracle 9i database with Oracle Business Intelligence Standard One edition which creates an Oracle interactive dashboard that allows companies to constantly access data and results. ARITHMOS has identified the following user requirements:

Accessibility to live data anytime, anywhere in accordance with regulatory requirements
Aggregated data; the ability to navigate, modify and interact with results
A flexible platform and an easy-to-use interface

The integration of Oracle AERS and Oracle Business Intelligence was designed to meet a specific need in the pharmacovigilance market: to provide a user-friendly platform that allows access real-time access to structured data. In October, ARITHMOS also successfully integrated Oracle Business Intelligence with the iPhone and the iPad, making data and results instantly available via an “app” and a WIFI connection.

ARITHMOS and its Contract Research Organisation partner, CROS NT, are investing in the future of the pharmacovigilance market. CROS NT began offering pharmacovigilance services in 2008 including safety management plans, Serious Adverse Effects (SAE) reporting and Safety Database Services.

16.12.11 CROS NT Group Donates To Local Cancer Research Organisation

mary.wieder — Fri, 16 Dec 2011 08:46:41 +0000

This holiday season, the CROS NT Group has donated to a bone marrow and cancer research organisation in Verona.

Verona, Italy (16 December 2011) – As the CROS NT Group prepares for its annual holiday dinner, the company still has not forgotten those in need. The CROS NT Group has donated to the Associazione Donatori Midollo Osseo e Ricerca (ADMOR), or the Association of Bone Marrow Donors and Research.

ADMOR focuses on research for leukemia and lymphoma as well as finding donors for bone marrow transplants. The organisation is located in Verona, Italy and is a cause supported frequently by ARITHMOS Chief Operating Officer, Stefano Piccoli.

The CROS NT Group employees all donated to the ADMOR by buying tickets for its annual lottery. All proceeds from the lottery will help fund ADMOR research projects. For more information, visit the ADMOR website at http://www.admor.org/ .

# # #

About CROS NT Group

CROS NT is a global functional service Contract Research Organisation with expertise in biostatistics and clinical data management, completing over 800 projects. The IT subsidiary, ARITHMOS, provides technology solutions – including ePRO and data integration– to increase clinical trial success rates. Project governance between data analysis and technology is our niche for superior clinicial trial results.

05.12.11 CROS NT To Attend Breast Cancer Symposium

mary.wieder — Mon, 05 Dec 2011 12:00:44 +0000

Head of Methodological Biostatistics, Lisa Comarella, is attending the annual Breast Cancer event in San Antonio, Texas.

Lisa Comrella, Head of Methodological Biostatistics for CROS NT, has been invited to attend the CTRC-AACR San Antonio Breast Cancer Symposium taking place December 6-10 in San Antonio, Texas.

The Breast Cancer Symposium is promoted by ASCO – the American Society of Clinical Oncology, which is a “professional oncology society committed to conquering cancer through research, education, prevention and delivery of high quality patient care”.

CROS NT is dedicated to clinical research and clinical trials in oncology. As a therapeutic area of expertise, CROS NT has done hundreds of studies in the field of oncology by providing statistical analysis and data management. Chief Operating Officer, Thomas Zwingers, and Comarella lead the CROS NT group in oncology study experience.

Comarella has been a statistician at CROS NT since 2001 and in February 2011 assumed the role of Head of Methodological Biostatistics and Senior Project Manager. She is participating in the Breast Cancer Symposium in San Antonio as an experienced statistician in oncology clinical trials with a special interest in breast cancer. Comarella’s commitment to ASCO and the Breast Cancer Symposium show CROS NT’s desire to expand its expertise in oncology clinical trial data analysis to the U.S. market.

Related Links:
CROS NT Biostatistics: http://www.cros.it/biostatistics
ASCO: http://www.asco.org/
San Antonio Breast Cancer Symposium: http://www.sabcs.org/

For more information, please contact Marketing Officer, Mary Wieder, at mary.wieder@crosnt.com.